These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 11228756

  • 21. Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. The Finnish Acargbos Study Group.
    Lindström J, Tuomilehto J, Spengler M.
    Diabet Med; 2000 Jan; 17(1):20-5. PubMed ID: 10691155
    [Abstract] [Full Text] [Related]

  • 22. Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.
    Schnell O, Mertes G, Standl E, Acarbose-Insulin Combination Study Group.
    Diabetes Obes Metab; 2007 Nov; 9(6):853-8. PubMed ID: 17924867
    [Abstract] [Full Text] [Related]

  • 23. Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.
    Delgado H, Lehmann T, Bobbioni-Harsch E, Ybarra J, Golay A.
    Diabetes Metab; 2002 Jun; 28(3):195-200. PubMed ID: 12149599
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
    Bao YQ, Zhou J, Zhou M, Cheng YJ, Lu W, Pan XP, Tang JL, Lu HJ, Jia WP.
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study.
    Hasche H, Mertes G, Bruns C, Englert R, Genthner P, Heim D, Heyen P, Mahla G, Schmidt C, Schulze-Schleppinghof B, Steger-Johannsen G.
    Diabetes Nutr Metab; 1999 Aug; 12(4):277-85. PubMed ID: 10782754
    [Abstract] [Full Text] [Related]

  • 31. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44).
    Holman RR, Cull CA, Turner RC.
    Diabetes Care; 1999 Jun; 22(6):960-4. PubMed ID: 10372249
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients.
    Fischer S, Patzak A, Rietzsch H, Schwanebeck U, Köhler C, Wildbrett J, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M.
    Diabetes Obes Metab; 2003 Jan; 5(1):38-44. PubMed ID: 12542723
    [Abstract] [Full Text] [Related]

  • 34. Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.
    Derosa G, Mereu R, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, Palumbo I, Maffioli P, Randazzo S, Cicero AF.
    J Clin Pharm Ther; 2010 Oct; 35(5):565-79. PubMed ID: 20831680
    [Abstract] [Full Text] [Related]

  • 35. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C, Haupt E, Walter T, Werner J.
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [Abstract] [Full Text] [Related]

  • 38. Acarbose and nutrient intake in non-insulin dependent diabetes mellitus.
    Tuomilehto J, Pohjola M, Lindström J, Aro A.
    Diabetes Res Clin Pract; 1994 Dec 31; 26(3):215-22. PubMed ID: 7736902
    [Abstract] [Full Text] [Related]

  • 39. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment.
    Calle-Pascual AL, Garcia-Honduvilla J, Martin-Alvarez PJ, Vara E, Calle JR, Munguira ME, Marañes JP.
    Diabete Metab; 1995 Oct 31; 21(4):256-60. PubMed ID: 8529760
    [Abstract] [Full Text] [Related]

  • 40. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.
    Clin Ther; 2011 Dec 31; 33(12):1932-42. PubMed ID: 22078152
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.